{"id":"https://openalex.org/W2052575805","doi":"https://doi.org/10.1016/j.vascn.2008.05.128","title":"Zebrafish: The future of in vivo safety pharmacology screening","display_name":"Zebrafish: The future of in vivo safety pharmacology screening","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W2052575805","doi":"https://doi.org/10.1016/j.vascn.2008.05.128","mag":"2052575805"},"language":"en","primary_location":{"id":"doi:10.1016/j.vascn.2008.05.128","doi":"https://doi.org/10.1016/j.vascn.2008.05.128","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2008.05.128","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027332996","display_name":"St\u00e9phane Berghmans","orcid":"https://orcid.org/0000-0001-5414-8674","observed_orcids":["https://orcid.org/0000-0001-5414-8674"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Berghmans","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059017804","display_name":"Teresa Pereira de Barros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T. Barros","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023145787","display_name":"Zoe J. Golder","orcid":"https://orcid.org/0009-0004-7662-1329","observed_orcids":["https://orcid.org/0009-0004-7662-1329"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Z. Golder","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109164951","display_name":"I. Gardner","orcid":"https://orcid.org/0000-0001-6050-8795","observed_orcids":["https://orcid.org/0000-0001-6050-8795"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I. Gardner","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113956344","display_name":"Paul Butler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Butler","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Hill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Hill","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053561369","display_name":"Angeleen Fleming","orcid":"https://orcid.org/0000-0003-3721-7126","observed_orcids":["https://orcid.org/0000-0003-3721-7126"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Fleming","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000558940","display_name":"Wendy K. ALDERTON","orcid":"https://orcid.org/0000-0003-0258-0451","observed_orcids":["https://orcid.org/0000-0003-0258-0451"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W. Alderton","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111700973","display_name":"Alan G. Roach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Roach","raw_affiliation_strings":["VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","Pfizer Global Research and Development, Sandwich, UK","VASTox, Abingdon, UK","VASTox, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VASTox, Cambridge, UK; VASTox, Abingdon, UK; Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"Pfizer Global Research and Development, Sandwich, UK","institution_ids":["https://openalex.org/I189718659"]},{"raw_affiliation_string":"VASTox, Abingdon, UK","institution_ids":[]},{"raw_affiliation_string":"VASTox, Cambridge, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I189718659"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"58","issue":"2","first_page":"177","last_page":"178"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11685","display_name":"Zebrafish Biomedical Research Applications","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11685","display_name":"Zebrafish Biomedical Research Applications","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10447","display_name":"Environmental Toxicology and Ecotoxicology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zebrafish","display_name":"zebrafish","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety-testing","display_name":"drug safety testing","score":0.8410000205039978}],"concepts":[{"id":"https://openalex.org/C2776878037","wikidata":"https://www.wikidata.org/wiki/Q169444","display_name":"Zebrafish","level":3,"score":0.8927777409553528},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7152511477470398},{"id":"https://openalex.org/C2776190711","wikidata":"https://www.wikidata.org/wiki/Q7398663","display_name":"Safety pharmacology","level":3,"score":0.7058453559875488},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6583570241928101},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4033786654472351},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36282986402511597},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30956870317459106},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.1226428747177124},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.08807834982872009},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0664660632610321},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.03649362921714783}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vascn.2008.05.128","doi":"https://doi.org/10.1016/j.vascn.2008.05.128","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.vascn.2008.05.128","pdf_url":null,"source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2062184879","https://openalex.org/W2032083537","https://openalex.org/W2063842102","https://openalex.org/W2025388850","https://openalex.org/W1980545235","https://openalex.org/W7127390619","https://openalex.org/W2315884249","https://openalex.org/W2580890311","https://openalex.org/W2012042490","https://openalex.org/W2605932951"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}